Rallybio Corp Balance Sheet
RLYB|2 years of annual SEC 10-K data (FY2024-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 2 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Total Assets
$62M
FY2025
Cash
$31M
Cash and equivalents
Total Debt
N/A
FY2025
Shareholder Equity
$62M
FY2025
Rallybio Corp had $62M in total assets and $62M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score NaN (distress zone, below 1.23 threshold)
- Currently unprofitable: Net income is negative
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 |
|---|---|---|
| Cash & Equivalents | $31.4M | $13.9M |
| Current Assets | $61.3M | $67.8M |
| PP&E (Net) | $23.0K | $115.0K |
| Total Assets | $62.3M | $68.1M |
| Current Liabilities | $4.2M | $6.2M |
| Shareholders' Equity | $61.7M | $106.2M |